Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Iressa under regulatory review in two major markets for NSCLC

Jan. 29, 2002

Human Genome Sciences submits IND for B-cell-targeting LymphoRad

Jan. 28, 2002

Cell Pathways updates phase IIa program of CP-461 in cancer

Jan. 28, 2002

Tubulin-binding agents from AstraZeneca with antiangiogenic activity

Jan. 25, 2002

FDA approval granted for Eligard 7.5 mg, formerly Leuprogel One-Month Depot

Jan. 25, 2002

Merck's European C225 program progresses as planned despite U.S. setback

Jan. 25, 2002

MVA-Muc1-IL-2 enters phase II trials in lung and breast cancers

Jan. 25, 2002

Amino-substituted carbothioic acid esters that act as apoptosis inducers

Jan. 24, 2002

Introgen receives grant to evaluate INGN-241 in melanoma

Jan. 24, 2002

Kosan researchers design epothilone derivatives with antitumor activity

Jan. 23, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...